Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Author Archives: MissionIR

MissionIRNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Moves Forward to Strengthen the Case for HyBryte(TM)

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company, is advancing its phase 3 replication study (“FLASH2”) for HyBryte(TM), a novel photodynamic therapy designed to treat early-stage cutaneous T-cell lymphoma (“CTCL”). Building on the success of a prior phase 3 trial, HyBryte(TM)—which … Continue reading

Posted in Soligenix Inc. SNGX | Leave a comment

MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Reports Positive VALID-ECG Study Results Supporting 12-Lead ECG Technology

HeartBeam (NASDAQ: BEAT) announced that its synthesized 12-lead ECG technology met clinical endpoints in the VALID-ECG pivotal study, achieving a 93.4% diagnostic agreement with standard 12-lead ECGs for arrhythmia assessment. Results were presented by Dr. Thomas Deering of Piedmont Heart Institute … Continue reading

Posted in HeartBeam Inc. BEAT | Leave a comment

MissionIRNewsBreaks – NextPlat Corp (NASDAQ: NXPL) Receives Nasdaq Notice for Minimum Bid Price Noncompliance

NextPlat (NASDAQ: NXPL, NXPLW) announced it has received a written notice from Nasdaq Stock Market LLC stating that the company is not in compliance with Nasdaq Listing Rule 5550(a)(2), as its closing bid price has remained below $1.00 per share for … Continue reading

Posted in NextPlat Corp. NXPL | Leave a comment

MissionIRNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Launches Newton Fast Motion Shaft for Enhanced Swing Speed and Control

Newton Golf Company (NASDAQ: NWTG) announced the launch of its newest shaft family, Newton Fast Motion, now available for purchase at a suggested retail price of $325. The lighter, Tour-proven shaft is engineered to deliver exceptional precision and enhanced swing speed, … Continue reading

Posted in Newton Golf Comp. NWTG | Leave a comment

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Reports Innovative RTNova Platform Research, Exemplifies Pivotal Role of Research

Cancer remains one of the most formidable health challenges worldwide, necessitating relentless research to uncover effective treatments. Continuous scientific inquiry has led to groundbreaking therapies, offering hope to millions. A recent development in this arena is Calidi Biotherapeutics’ (NYSE American: … Continue reading

Posted in Calidi Biotherapeutics Inc. CLDI | Leave a comment

MissionIRNewsBreaks – Why Nutriband Inc. (NASDAQ: NTRB) Is ‘One to Watch’ 

Nutriband Inc. (NTRB)
Continue reading

Posted in Small Cap News | Leave a comment

MissionIRNewsBreaks – Platinum Group Metals Ltd.’s (NYSE American: PLG) (TSX: PTM) Waterberg Project Poised to Fuel Modern Tech with Critical PGMs

Platinum Group Metals (NYSE American: PLG) (TSX: PTM) is strategically positioning itself to become a key player in the expanding platinum group metals (“PGMs”) sector, driven by the essential role of PGMs in next-gen technology and industrial applications. PGMs serve critical … Continue reading

Posted in Platinum Group Metals Ltd. PLG | Leave a comment

D-Wave Quantum Inc. (NYSE: QBTS) and Japan Tobacco Complete Quantum AI Project Designed to Improve Drug Discovery Outcomes

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the pharmaceutical division of Japan Tobacco Inc. (“JT”), have announced the successful completion of a proof-of-concept project applying quantum computing and artificial intelligence (“AI”) to … Continue reading

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) to Report First Quarter Fiscal Year 2025 Financial Results on May 8

D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in the development and delivery of quantum computing systems, software, and services, will release its first-quarter fiscal 2025 results before market open on Thursday, May 8, 2025. D-Wave will host a conference call featuring CEO … Continue reading

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

MissionIRNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Featured in Benzinga Video Highlighting 75% HyBryte™ Response Rate in FDA-Backed Skin Cancer Trial

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on rare diseases, is featured in a new Benzinga video detailing clinical progress for its lead candidate HyBryte™, which achieved a 75% response rate in a trial for cutaneous T-cell lymphoma (CTCL), … Continue reading

Posted in Soligenix Inc. SNGX | Leave a comment